Clinical Trial

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

Name: Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C — clinical trial record (NCT05905926)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 3

View on ClinicalTrials.gov →

Summary

Open-label long-term safety study of tenapanor in pediatric patients with IBS-C.

Protocol Amendment History 1 change

notable Trial sites expanded: 22 -> 26 locations 2026-05-13

Trial Details

NCT Number	NCT05905926
Lead Sponsor	Ardelyx
Conditions	Irritable Bowel Syndrome With Constipation (IBS-C)
Enrollment	150 participants
Start Date	2023-02-17
Primary Completion	2031-07 (estimated)
Study Completion	2031-10 (estimated)
Updated on ClinicalTrials.gov	2026-06-04